Apollo Therapeutics Archives

Home Apollo Therapeutics

Latest Posts

News and Trends 12 Apr 2017

Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics

Swiss Polyphor has closed a €37M (CHF40M) private funding round to finance the development of its most advanced candidate tackling antibiotic resistances. Polyphor is a clinical stage pharma developing a…

April 12, 2017 - 3 minutesmins - By Melanie De Almeida

Apollo Therapeutics drug discovery launch

News and Trends 22 Feb 2017

UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off

Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research. Its first four drug discovery programmes will now be launched. Apollo Therapeutics was founded in early 2016…

February 22, 2017 - 2 minutesmins - By Melanie De Almeida

medicxi venture index fund uk genmab jjdc gsk fund

News and Trends 2 Feb 2016

New €210M Life Sciences Fund is Launched in UK

Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210M Fund including GSK and Johnson & Johnson Innovation. Medicxi Ventures is based…

February 2, 2016 - 2 minutesmins - By Dani Bancroft

cambridge gsk ucl imperial apollo jj astrazeneca

News and Trends 27 Jan 2016

New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas

AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College London and the University of Cambridge) have joined forces to found the 'Apollo' Bridge. This…

January 27, 2016 - 3 minutesmins - By Dani Bancroft

Resources

Categories

The latest news on

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

Americas

Asia Pacific

Europe

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Company

Join Us

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering